LRMRLarimar Therapeutics, Inc.Sep 29, 2025Q1 2023
Read transcript →Larimar Therapeutics, Inc. (LRMR) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.53
+5.86%
Mkt Cap $251.40M
LRMRLarimar Therapeutics, Inc.Sep 29, 2025LRMRLarimar Therapeutics, Inc.Sep 29, 2025